Posted in | News | Signal Processing

Image Sensing Systems Releases Autoscope RTMS Sx-300 for Advanced Vehicle Detection

Image Sensing Systems. Inc., the industry leading developer of Intelligent Transportation Systems (ITS) above-ground detection technology, announced today the addition of the Autoscope® RTMS® Sx-300 to its traffic management product line.

The Autoscope RTMS Sx-300 provides advanced vehicle detection with the accuracy needed to help keep the daily commute free of congestion. The Sx-300 provides the best lane detection capabilities available on the market, providing the ability to detect up to 12 lanes of simultaneous detection reporting of vehicle presence as well as volume, occupancy, speed and classification information.

"We are pleased to announce the addition of the Autoscope RTMS Sx-300 to our vehicle detection portfolio," said Nathan Silver, Product Manager for Traffic Management. "After many years of innovative development driven by the voice of our customers, we are pleased to be able to address the concerns of the transportation sector by offering a radar detection solution with increased reliability and longevity."

The Autoscope RTMS Sx-300 provides a fully automated set-up feature that self-detects and self-calibrates detection zones, providing users with a simple and cost effective installation process. Additionally, the Autoscope RTMS Sx-300 continues to provide the industry leading Zero SetbackTM capability and offers a best in class five-year warranty.

The combination of the Autoscope RTMS Sx-300 and the sophisticated CitySync Metro software provide today's traffic engineers with clarifying analytics that make data more actionable. These technologies help move traffic safely and efficiently in real-time providing the clarity and confidence needed to make proactive decisions.

Image Sensing Systems will be featuring the Autoscope RTMS Sx-300 in stand #11.503 at Intertraffic March 25th through March 28th in Amsterdam, Netherlands. For more information, visit imagesensing.com.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.